a b s t r a c t G protein-coupled receptor 91 (GPR91) is a succinate-specific receptor and activation of GPR91 could initiate a complex signal transduction cascade and upregulate inflammatory and pro-angiogenic cytokines. In the retina, GPR91 is predominately expressed in ganglion cells, a major cellular entity involved in the pathogenesis of diabetic retinopathy (DR) and other hypoxic retinal diseases. During the development of DR and retinopathy of prematurity (ROP), chronic hypoxia causes an increase in the levels of local succinate. Succinate-mediated GPR91 activation upregulates vascular endothelial growth factor (VEGF) through ERK1/2-C/EBP b (c-Fos) and/or ERK1/2-COX-2/PGE2 signaling pathways, which in turn, leads to the breakdown of blood-retina barriers in these disorders. In this review, we will have a brief introduction of GPR91 and its biological functions and a more detailed discussion about the role and mechanisms of GPR91 in DR and ROP. A better understanding of GPR91 regulation may be of great significance in identifying new biomarkers and drug targets for the prediction and treatment of DR, ROP, and hypoxic retinal diseases.
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Introduction
The retina is the most metabolically active tissue and consumes a large amount of energy. Insufficient supplies of oxygen and nutrients in the retina may impair cellular oxygen balance and result in a hypoxic retinal environment that disturbs physiological processes and leads to pathological characteristics in the retina (Caprara & Grimm, 2012) . During the progression of diabetes, hyperglycemia or high levels of retinal glucose causes hypoxia and oxygen imbalance, which is, at least partially, responsible for microaneurysms, hard exudates, hemorrhages, cotton-wool spots, and retinal neovascularization, major clinical features of diabetic retinopathy (DR) (Antonetti, Klein, & Gardner, 2012). Although not identical, the mechanisms for vascular leakage and retinal neovascularization in DR are very similar to those in retinopathy of prematurity (ROP), a disease of abnormal vascular development in infants that could lead to retinal detachment and cause vision loss (Gunay et al., 2016) . DR and ROP are now considered as neurovascular diseases, since functional and structural alterations of the neurosensory retina in DR and ROP are found with electroretinography, psychophysical and retinal imaging processes (Hansen, Moskowitz, Akula, & Fulton, 2016) . The mechanisms for retinal neuronal degeneration in DR may also share similarities to those in glaucoma, a disease resulted from insufficient supply of oxygen or nutrients. Extensive evidences confirm that G protein-coupled receptor 91 (GPR91), which is now widely regarded as the endogenous receptor for succinate, is involved in the development of hypoxic retinal vascular diseases (Gnana-Prakasam, Ananth, Prasad, et al., 2011; Hu, Li, Du, et al., 2015; Hu, Wu, Li, Chen, & Wang, 2013; Sapieha, Sirinyan, Hamel, et al., 2008) . Under hypoxic conditions, GPR91 activation causes damages to retinal cells by upregulating cytokine expression and by inducing angiogenesis in the retina. In this review, we will have a brief introduction of GPR91 biological function and a more detailed discussion about the role and mechanisms of GPR91 in DR and ROP.
GPR91 as succinate receptor
Succinate is traditionally considered as a Krebs cycle intermediate with no apparent role as a signaling molecule for a long-time http://dx.doi.org/10.1016/j.visres.2017.05.001 0042-6989/Ó 2017 Elsevier Ltd. All rights reserved.
